Prediction of longitudinal synaptic loss in Alzheimer's disease using tau PET and plasma biomarkers

Documenti analoghi

• Connectivity to epicenters of tau accumulation contributes to regional synaptic loss in Alzheimer’s disease
  di: Ying Luan, et al.
  Pubblicazione: (2024)
• Impaired glymphatic function is associated with synaptic loss by SV2A PET in Alzheimer's Disease
  di: Kun He, et al.
  Pubblicazione: (2025)
• Imaging of amyloid, tau and synaptic dysfunction in the brains of type 2 diabetic rats ‐ a multitracer PET study
  di: Yanyan Kong, et al.
  Pubblicazione: (2024)
• Impaired glymphatic function exacerbates tau propagation and the effect of tau pathology on cognitive decline in Alzheimer's disease
  di: Ying Luan, et al.
  Pubblicazione: (2025)
• Tau pathology is associated with postsynaptic metabotropic glutamate receptor 5 (mGluR5) in early Alzheimer's disease in a sex‐specific manner
  di: Yan Wang, et al.
  Pubblicazione: (2025)